Abstract
During brain development, neuronal and glial cells are generated from neural precursors on a precise schedule involving steps of proliferation, fate commitment and differentiation. We report that telomerase activity is highly expressed during embryonic murine cortical neurogenesis and early steps of gliogenesis and progressively decreases thereafter during cortex maturation to be undetectable in the normal adult brain. We evidenced neural precursor cells (NPC) as the principal telomerase-expressing cells in primary cultures from E15 mouse embryo cortices. Their differentiation either in neurons or in glial cells lead to a down regulation of telomerase activity that was directly correlated to the decrease of telomerase core protein (mTERT) mRNA synthesis. Furthermore, we show that FGF2 (fibroblast growth factor 2), one of the main regulators of CNS development, induces a dose-dependant increase of both the proliferation of NPC and telomerase activity in primary cortical cultures without affecting the mTERT mRNA synthesis compared to that of glyceraldehyde-3-phosphate dehydrogenase (mGAPDH). Finally, we evidenced that AZT (3′-azido-2′,3′-dideoxythymidine), known to inhibit telomerase activity, blocks in a dose dependant manner the FGF2-induced proliferation of NPC. Altogether, our results are in favor of an important role of telomerase activity during brain organogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Abbreviations
- NPC:
-
neural precursor cells
- FGF2:
-
fibroblast growth factor 2
- NGF:
-
nerve growth factor
- TERT:
-
telomerase reverse transcriptase protein
- TER:
-
telomerase RNA
- AZT:
-
3′-azido-2′,3′-dideoxythymidine
References
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB . 1992 Proc Natl Acad Sci USA 89: 10114–10118
Altman J and Das GD . 1965 J Comp Neurol 124: 319–335
Blackburn EH . 1991 Nature 350: 569–573
Blasco MA, Funk W, Villeponteau B and Greider CW . 1995 Science 269: 1267–1270
Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW . 1997 Cell 91: 25–34
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE . 1998 Science 279: 349–352
Cameron HA, Hazel TG and McKay RD . 1998 J Neurobiol 36: 287–306
Cattaneo E and McKay R . 1990 Nature 347: 762–765
Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and de Lange T . 1995 Science 270: 1663–1667
Datta K, Bellacosa A, Chan TO and Tsichlis PN . 1996 J Biol Chem 271: 30835–30839
Dono R, Texido G, Dussel R, Ehmke H and Zeller R . 1998 EMBO J 17: 4213–4225
Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W and Moore MA . 1997 Blood 90: 182–193
Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West ND, Harley CB, Andrews WH, Grieder CW and Villeponteau B . 1995 Science 269: 1236–1241
Fu W, Begley JG, Killen MW and Mattson MP . 1999 J Biol Chem 274: 7264–7271
Gage FH, Coatesn PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST and Ray J . 1995 Proc Natl Acad Sci USA 92: 11879–11883
Ghosh A and Greenberg ME . 1995 Neuron 15: 89–103
Giordano S, Sherman L, Lyman W and Morrison R . 1992 Dev Biol 152: 293–303
Gomez DE, Tejera AM and Olivero OA . 1998 Biochem Biophys Res Commun 246: 107–110
Gray GE, Glover JC, Majors J and Sanes JR . 1988 Proc Natl Acad Sci USA 85: 7356–7360
Greenberg RA, Allsopp RC, Chin L, Morin GB and DePinho RA . 1998 Oncogene 16: 1723–1730
Greider CW . 1991 Mol Cell Biol 11: 4572–4580
Greider CW and Blackburn EH . 1985 Cell 43: 405–413
Harley CB . 1991 Mutat Res 256: 271–282
Harley CB, Futcher AB and Greider CW . 1990 Nature 345: 458–460
Herrera E, Samper E and Blasco MA . 1999a EMBO J 18: 1172–1181
Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW and Blasco MA . 1999b EMBO J 18: 2950–2960
Hiratochi M, Fujiwara A, Kitani H, Iguchi T, Sakakura T and Tomooka Y . 1998 Dev Growth Differ 40: 59–65
Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW . 1995 Nat Med 1: 249–255
Holt SE, Wright WE and Shay JW . 1996 Mol Cell Biol 16: 2932–2939
Ito H, Kyo S, Kanaya T, Takakura M, Inoue M and Namiki M . 1998 Clin Cancer Res 4: 1603–1608
Janet T, Ludecke G, Otten U and Unsicker K . 1995 J Neurosci Res 40: 707–715
Joy A, Moffett J, Neary K, Mordechai E, Stachowiak EK, Coons S, Rankin-Shapiro J, Florkiewicz RZ and Stachowiak MK . 1997 Oncogene 14: 171–183
Kang SS, Kwon T, Kwon DY and Do SI . 1999 J Biol Chem 274: 13085–13090
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW . 1994 Science 266: 2011–2015
Kruk PA, Balajee AS, Rao KS and Bohr VA . 1996 Biochem Biophys Res Commun 224: 487–492
Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW and DePinho RA . 1998 Nature 392: 569–574
Lendahl U, Zimmerman LB and McKay RD . 1990 Cell 60: 585–595
Makarov VL, Hirose Y and Langmore JP . 1997 Cell 88: 657–566
Martin-Rivera L, Herrera E, Albar JP and Blasco MA . 1998 Proc Natl Acad Sci USA 95: 10471–10476
Melana SM, Holland JF and Pogo BG . 1998 Clin Cancer Res 4: 693–696
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA . 1997 Cell 90: 785–795
Miho Y, Kouroku Y, Fujita E, Mukasa T, Urase K, Kasahara T, Isoai A, Momoi MY and Momoi T . 1999 Cell Death Differ 6: 463–470
Miyagi N, Kato S, Terasaki M, Shigemori M and Morimatsu M . 1998 Int J Oncol 12: 1085–1090
Multani AS, Furlong C and Pathak S . 1998 Int J Oncol 13: 923–925
Murphy M, Reid K, Ford M, Furness JB and Bartlett PF . 1994 Development 120: 3519–3528
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR . 1997 Science 277: 955–959
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T and Ishikawa F . 1998 Nat Genet 18: 65–68
Olivero OA and Poirier MC . 1993 Mol Carcinog 8: 81–88
Peyrin JM, Lasmezas CI, Haik S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys JP and Dormont D . 1999 Neuroreport 10: 723–729
Prowse KR and Greider CW . 1995 Proc Natl Acad Sci USA 92: 4818–4822
Qian X, Davis AA, Goderie SK and Temple S . 1997 Neuron 18: 81–93
Ray J, Baird A and Gage FH . 1997 Proc Natl Acad Sci USA 94: 7047–7052
Reichman TW, Albanell J, Wang X, Moore MA and Studzinski GP . 1997 J Cell Biochem 67: 13–23
Reynolds BA, Tetzlaff W and Weiss S . 1992 J Neurosci 12: 4565–4574
Reynolds BA and Weiss S . 1996 Dev Biol 175: 1–13
Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT and Narayanan R . 1995 Proc Natl Acad Sci USA 92: 12343–12346
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . 1998 Cell 95: 29–39
Strahl C and Blackburn EH . 1996 Mol Cell Biol 16: 53–65
Takakura M, Kyo S, Kanaya T, Tanaka M and Inoue M . 1998 Cancer Res 58: 1558–1561
Tian XX, Pang JC, To SS and Ng HK . 1999 J Neuropathol Exp Neurol 58: 472–479
Turner DL and Cepko CL . 1987 Nature 328: 131–136
Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ and Hung YT . 1999 Nat Neurosci 2: 246–253
Vaziri H and Benchimol S . 1998 Curr Biol 8: 279–282
van Weering DH, de Rooij J, Marte B, Downward J, Bos JL and Burgering BM . 1998 Mol Cell Biol 18: 1802–1811
Weng NP, Levine BL, June CH and Hodes RJ . 1996 J Exp Med 183: 2471–2479
Weng NP, Palmer LD, Levine BL, Lane HC, June CH and Hodes RJ . 1997 Immunol Rev 160: 43–54
Xu D, Gruber A, Bjorkholm M, Peterson C and Pisa P . 1999 Br J Cancer 80: 1156–1161
Yamaguchi Y, Nozawa K, Savoysky E, Hayakawa N, Nimura Y and Yoshida S . 1998 Exp Cell Res 242: 120–127
Zhu J, Wang H, Bishop JM and Blackburn EH . 1999 Proc Natl Acad Sci USA 96: 3723–3728
Zhu X, Kumar R, Mandal M, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R and Narayanan R . 1996 Proc Natl Acad Sci USA 93: 6091–6095
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haïk, S., Gauthier, L., Granotier, C. et al. Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene 19, 2957–2966 (2000). https://doi.org/10.1038/sj.onc.1203596
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1203596
Keywords
This article is cited by
-
Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells
Journal of Hematology & Oncology (2022)
-
Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury
Journal of Neuroimmune Pharmacology (2021)
-
Telomere and telomerase in stem cells
British Journal of Cancer (2007)
-
Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation
Oncogene (2004)
-
Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway
Oncogene (2002)